BRAF (V600E) Mutation Analysis in Papillary Thyroid Carcinomas by Peptide Nucleic Acid Clamp Real-time PCR
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jeong, Dongjun | - |
dc.contributor.author | Jeong, Yujun | - |
dc.contributor.author | Park, Ji Hye | - |
dc.contributor.author | Han, Sun Wook | - |
dc.contributor.author | Kim, Sung Yong | - |
dc.contributor.author | Kim, Yeo Joo | - |
dc.contributor.author | Kim, Sang Jin | - |
dc.contributor.author | Hwangbo, Young | - |
dc.contributor.author | Park, Soyoung | - |
dc.contributor.author | Cho, Hyun Deuk | - |
dc.contributor.author | Oh, Mee Hye | - |
dc.contributor.author | Yang, Seung Ha | - |
dc.contributor.author | Kim, Chang Jin | - |
dc.date.accessioned | 2021-08-12T01:18:57Z | - |
dc.date.available | 2021-08-12T01:18:57Z | - |
dc.date.issued | 2013-03 | - |
dc.identifier.issn | 1068-9265 | - |
dc.identifier.issn | 1534-4681 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/13870 | - |
dc.description.abstract | Activating somatic mutation of the BRAF (V600E) has been identified as the most common genetic event in papillary thyroid carcinoma (PTC) with a variable frequency (32-87 %) in different series by different methods. The BRAF (V600E) mutation is associated with various clinicopathological parameters. The mutation is an important factor for the management of the PTC patients. The objective of this study was to detect the BRAF (V600E) mutation in PTCs by peptide nucleic acid (PNA) clamp real-time PCR and to analyze the results with clinicopathological parameters. We performed genetic analysis of BRAF (V600E) by PNA clamp real-time PCR in 211 PTCs in Korea, stratified by clinicopathological parameters. The BRAF (V600E) mutation was detected in 90 % of PTC cases, and it occurred significantly more often in female patients than in male patients (p = 0.001). The clinicopathological parameters of age, tumor size, and disease stage were not associated with the BRAF (V600E) mutation, while extrathyroid invasion (p = 0.031), lymph nodal metastasis (p = 0.002), and tumor multiplicity (p = 0.020) were. The prevalence (90 %) of the BRAF (V600E) mutation in this study is the highest ever reported, confirming the key role of this mutation in PTC tumorigenesis. The BRAF (V600E) mutation was associated with aggressive clinical behaviors including extrathyroid invasion, lymph nodal metastasis and tumor multifocality. The PNA clamp real-time PCR method for the BRAF (V600E) mutation detection is sensitive and is applicable in a clinical setting. | - |
dc.format.extent | 8 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Lippincott Williams & Wilkins Ltd. | - |
dc.title | BRAF (V600E) Mutation Analysis in Papillary Thyroid Carcinomas by Peptide Nucleic Acid Clamp Real-time PCR | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1245/s10434-012-2494-0 | - |
dc.identifier.scopusid | 2-s2.0-84875222136 | - |
dc.identifier.wosid | 000314998000010 | - |
dc.identifier.bibliographicCitation | Annals of Surgical Oncology, v.20, no.3, pp 759 - 766 | - |
dc.citation.title | Annals of Surgical Oncology | - |
dc.citation.volume | 20 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 759 | - |
dc.citation.endPage | 766 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Surgery | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Surgery | - |
dc.subject.keywordPlus | URINARY IODINE EXCRETION | - |
dc.subject.keywordPlus | BRAF(V600E) MUTATION | - |
dc.subject.keywordPlus | GENE MUTATION | - |
dc.subject.keywordPlus | SENSITIVE DETECTION | - |
dc.subject.keywordPlus | COLORECTAL-CANCER | - |
dc.subject.keywordPlus | HIGH PREVALENCE | - |
dc.subject.keywordPlus | TUMORS | - |
dc.subject.keywordPlus | AMPLIFICATION | - |
dc.subject.keywordPlus | COHORT | - |
dc.subject.keywordPlus | CELLS | - |
dc.subject.keywordAuthor | BRAF Papillary Thyroid Carcinomas | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.